All In Biotech

Drug Trial Radar · NCT03796962

A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 as Adjunctive Therapy in Focal-onset Epilepsy, With an Open-label Extension

Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registryPivotal-lookingRandomized with 325 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

325

Actual

Start

Jan 30, 2019

Primary completion

Sep 2, 2021

Study completion Oct 2030

Sponsor

Lead sponsor
Xenon Pharmaceuticals Inc.Industry
Sponsor type
Industry
Collaborators
Novotech Health Holdings Pte. Ltd.
First posted
Jan 8, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The XEN1101 Phase 2 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety and tolerability of increasing doses of XEN1101 administered as adjunctive treatment in adult patients diagnosed with focal epilepsy, followed by an optional open-label extension (OLE).

Conditions

  • Focal Epilepsy

Interventions

  • XEN1101Drug

    Oral dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Median Percent Change in Focal Seizure FrequencyTime frame: From baseline (8 weeks prior to Day 0) through to the final dose (up to Day 56)

Locations

95 sites in 9 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Strada Patient Care Center

    Mobile, Alabama

  • Xenoscience, Inc.

    Phoenix, Arizona

  • Clinical Trials, Inc.

    Little Rock, Arkansas

  • Altman Clinical Translational Research Institute (ACTRI)

    La Jolla, California

  • California Pacific Medical Center (CPMC) - Sutter Pacific Epilepsy Program

    San Francisco, California

  • University of Colorado Hospital Anschutz Outpatient Pavilion

    Aurora, Colorado

  • University of Florida Jacksonville

    Jacksonville, Florida

  • Mayo Clinic Florida

    Jacksonville, Florida

  • Visionary Investigators Network

    Miami, Florida

  • Don Clinical Research Center

    Miami, Florida

  • The Neurology Research Group, LLC.

    Miami, Florida

  • Research Institute of Orlando, LLC

    Orlando, Florida

  • Medsol Clinical Research Center

    Port Charlotte, Florida

  • Tallahassee Neurological Clinic

    Tallahassee, Florida

  • University of South Florida

    Tampa, Florida

  • Georgia Neurology and Sleep Medicine Associate

    Suwanee, Georgia

  • Hawaii Pacific Neuroscience

    Honolulu, Hawaii

  • Consultants in Epilepsy and Neurology, PLLC

    Boise, Idaho

  • Northwestern Medical Group, Department of Neurology

    Chicago, Illinois

  • University of Kansas Medical Center

    Kansas City, Kansas

  • Bluegrass Epilepsy Research

    Lexington, Kentucky

  • Maine Medical Partners Neurology

    Scarborough, Maine

  • Mid-Atlantic Epilepsy and Sleep Center

    Bethesda, Maryland

  • Boston Neuro Research Center

    Russells Mills, Massachusetts

  • Minneapolis Clinic of Neurology, Ltd.

    Golden Valley, Minnesota

  • Minnesota Epilepsy Group, P. A.

    Saint Paul, Minnesota

  • Northeast Regional Epilepsy Group

    Hackensack, New Jersey

  • Institute of Neurology and Neurosurgery at Saint Barnabas

    Livingston, New Jersey

  • Northeast Regional Epilepsy Group

    Morristown, New Jersey

  • Dent Neurosciences Research Center

    Amherst, New York

  • NYU Langone Medical Center/NYU School of Medicine

    New York, New York

  • Northwell Health - Lenox Hill

    New York, New York

  • SUNY Upstate Medical University Institute for Human Performance

    Syracuse, New York

  • Five Towns Neuroscience Research

    Woodmere, New York

  • Asheville Neurology Specialists, PA

    Asheville, North Carolina

  • UC Gardner Neuroscience Institute

    Cincinnati, Ohio

  • Miami Valley Hospital

    Dayton, Ohio

  • University of Toledo Medical Center

    Toledo, Ohio

  • Providence Neurological Specialties East

    Portland, Oregon

Showing 40 of 95 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.